Related Experiment Video
Updated: May 18, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA hypomethylation and activation of germline-specific genes in cancer
Charles De Smet1, Axelle Loriot
1Laboratory of Genetics and Epigenetics, de Duve Institute, Catholic University of Louvain, Brussels, Belgium. Charles.Desmet@uclouvain.be
Abstract:
DNA methylation, occurring at cytosines in CpG dinucleotides, is a potent mechanism of transcriptional repression. Proper genomic methylation -patterns become profoundly altered in cancer cells: both gains (hypermethylation) and losses (hypomethylation) of methylated sites are observed. Although DNA hypomethylation is detected in a vast majority of human tumors and affects many genomic regions, its role in tumor biology remains elusive. Surprisingly, DNA hypomethylation in cancer was found to cause the aberrant activation of only a limited group of genes. Most of these are normally expressed exclusively in germline cells and were grouped under the term "cancer-germline" (CG) genes. CG genes represent unique examples of genes that rely primarily on DNA methylation for their tissue-specific expression. They are also being exploited to uncover the mechanisms that lead to DNA hypomethylation in tumors. Moreover, as CG genes encode tumor-specific antigens, their activation in cancer highlights a direct link between epigenetic alterations and tumor immunity. As a result, clinical trials combining epigenetic drugs with anti-CG antigen vaccines are being considered.
Insights
DNA hypomethylation, a widespread change in cancer, unexpectedly activates specific cancer-germline (CG) genes. These genes, crucial for tumor immunity, offer new therapeutic targets.
Area of Science:
- Epigenetics
- Cancer Biology
- Genomics
Background:
- DNA methylation is a key epigenetic regulator of gene expression, primarily acting as a transcriptional repressor.
- Cancer cells exhibit widespread alterations in DNA methylation, including both hypermethylation and hypomethylation.
- The functional consequences of DNA hypomethylation in cancer remain largely unclear, despite its prevalence.
Purpose of the Study:
- To investigate the specific genes affected by DNA hypomethylation in cancer.
- To understand the role of DNA hypomethylation in tumor biology and its link to tumor immunity.
- To explore the therapeutic potential of targeting cancer-germline (CG) genes activated by hypomethylation.
Main Methods:
- Analysis of genomic methylation patterns in cancer cells.
- Identification of genes aberrantly activated due to DNA hypomethylation.
- Characterization of cancer-germline (CG) genes and their expression profiles.
- Evaluation of the immunogenicity of CG gene products as tumor-specific antigens.
Main Results:
- DNA hypomethylation in cancer leads to the aberrant activation of a distinct subset of genes.
- These activated genes are predominantly cancer-germline (CG) genes, normally restricted to germline cells.
- CG genes rely heavily on DNA methylation for their tissue-specific silencing.
- Activation of CG genes in tumors creates a link between epigenetic dysregulation and tumor immunity.
Conclusions:
- DNA hypomethylation in cancer selectively activates CG genes, contributing to tumor-specific antigen expression.
- CG genes represent a promising avenue for understanding cancer epigenetics and developing novel immunotherapies.
- Targeting CG genes via epigenetic drugs and vaccines holds potential for clinical applications in cancer treatment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Induced Pluripotent Stem Cells
Somatic cells are...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

